Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C A Heckman

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
The American Journal of Pathology|January 1, 1980
Ultrastructural characteristics of carcinogen-induced dysplastic changes in tracheal epitheliumA J Klein-Szanto, D C Topping, C A Heckman, et al.
Oncogene|April 21, 2001
Negative regulation of bcl-2 expression by p53 in hematopoietic cellsY Wu, J W Mehew, C A Heckman, et al.
Experimental Cell Research|October 1, 1984
Changes in cell-substratum adhesion and nuclear-cytoskeletal anchorage during cytodifferentiation of BeWo choriocarcinoma cellsS J Friedman, D Galuszka, I Gedeon, et al.
The Journal of Biological Chemistry|February 29, 2000
A-Myb up-regulates Bcl-2 through a Cdx binding site in t(14;18) lymphoma cellsC A Heckman, J W Mehew, G G Ying, et al.
Journal of Virology|December 1, 1995
Branchpoint and polypyrimidine tract mutations mediating the loss and partial recovery of the Moloney murine sarcoma virus MuSVts110 thermosensitive splicing phenotypeJ W Touchman, I D'Souza, C A Heckman, et al.
International Journal of Oncology|November 6, 2007
Pattern analysis of microtubule-polymerizing and -depolymerizing agent combinations as cancer chemotherapiesS O Uppal, Y Li, E Wendt, et al.
Experimental Cell Research|April 20, 2004
Novel p21-activated kinase-dependent protrusions characteristically formed at the edge of transformed cellsC A Heckman, J M Urban, M Cayer, et al.
Leukemia|July 28, 2016
Idelalisib sensitivity and mechanisms of disease progression in relapsed TCF3-PBX1 acute lymphoblastic leukemiaS Eldfors, H Kuusanmäki, M Kontro, et al.
Blood Cancer Journal|May 2, 2015
Novel drug candidates for blast phase chronic myeloid leukemia from high-throughput drug sensitivity and resistance testingP O Pietarinen, T Pemovska, M Kontro, et al.
Leukemia|August 9, 2016
HOX gene expression predicts response to BCL-2 inhibition in acute myeloid leukemiaM Kontro, A Kumar, M M Majumder, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
The American Journal of Pathology|January 1, 1980
Ultrastructural characteristics of carcinogen-induced dysplastic changes in tracheal epitheliumA J Klein-Szanto, D C Topping, C A Heckman, et al.
Oncogene|April 21, 2001
Negative regulation of bcl-2 expression by p53 in hematopoietic cellsY Wu, J W Mehew, C A Heckman, et al.
Experimental Cell Research|October 1, 1984
Changes in cell-substratum adhesion and nuclear-cytoskeletal anchorage during cytodifferentiation of BeWo choriocarcinoma cellsS J Friedman, D Galuszka, I Gedeon, et al.
The Journal of Biological Chemistry|February 29, 2000
A-Myb up-regulates Bcl-2 through a Cdx binding site in t(14;18) lymphoma cellsC A Heckman, J W Mehew, G G Ying, et al.
Journal of Virology|December 1, 1995
Branchpoint and polypyrimidine tract mutations mediating the loss and partial recovery of the Moloney murine sarcoma virus MuSVts110 thermosensitive splicing phenotypeJ W Touchman, I D'Souza, C A Heckman, et al.
International Journal of Oncology|November 6, 2007
Pattern analysis of microtubule-polymerizing and -depolymerizing agent combinations as cancer chemotherapiesS O Uppal, Y Li, E Wendt, et al.
Experimental Cell Research|April 20, 2004
Novel p21-activated kinase-dependent protrusions characteristically formed at the edge of transformed cellsC A Heckman, J M Urban, M Cayer, et al.
Leukemia|July 28, 2016
Idelalisib sensitivity and mechanisms of disease progression in relapsed TCF3-PBX1 acute lymphoblastic leukemiaS Eldfors, H Kuusanmäki, M Kontro, et al.
Blood Cancer Journal|May 2, 2015
Novel drug candidates for blast phase chronic myeloid leukemia from high-throughput drug sensitivity and resistance testingP O Pietarinen, T Pemovska, M Kontro, et al.
Leukemia|August 9, 2016
HOX gene expression predicts response to BCL-2 inhibition in acute myeloid leukemiaM Kontro, A Kumar, M M Majumder, et al.
Pageof 5